These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

12265 related articles for article (PubMed ID: 11668469)

  • 101. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
    Fitzgibbons PL; Chaurushiya PS; Nichols PW; Chandrasoma PT; Martin SE
    Hum Pathol; 1989 Mar; 20(3):269-72. PubMed ID: 2722176
    [TBL] [Abstract][Full Text] [Related]  

  • 102. A metastatic melanoma with an unusual immunophenotypic profile.
    Gao Z; Stanek A; Chen S
    Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The immunohistochemical identification of human oral mucosal melanocytes.
    Barrett AW; Raja AM
    Arch Oral Biol; 1997 Jan; 42(1):77-81. PubMed ID: 9134118
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Expression of microphthalmia transcription factor, S100 protein, and HMB-45 in malignant melanoma and pigmented nevi.
    Xia J; Wang Y; Li F; Wang J; Mu Y; Mei X; Li X; Zhu W; Jin X; Yu K
    Biomed Rep; 2016 Sep; 5(3):327-331. PubMed ID: 27602212
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification.
    Jurmeister P; Bockmayr M; Treese C; Stein U; Lenze D; Jöhrens K; Friedling F; Dietel M; Klauschen F; Marsch W; Fiedler E; von Laffert M
    J Dtsch Dermatol Ges; 2019 Aug; 17(8):800-808. PubMed ID: 31437373
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Immunohistochemical detection of melanoma-specific antigens in spontaneous canine melanoma.
    Sulaimon S; Kitchell B; Ehrhart E
    J Comp Pathol; 2002; 127(2-3):162-8. PubMed ID: 12354527
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Differential expression of MART-1, tyrosinase, and SM5-1 in primary and metastatic melanoma.
    Reinke S; Königer P; Herberth G; Audring H; Wang H; Ma J; Guo Y; Sterry W; Trefzer U
    Am J Dermatopathol; 2005 Oct; 27(5):401-6. PubMed ID: 16148409
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Expression patterns of MITF during human cutaneous embryogenesis: evidence for bulge epithelial expression and persistence of dermal melanoblasts.
    Gleason BC; Crum CP; Murphy GF
    J Cutan Pathol; 2008 Jul; 35(7):615-22. PubMed ID: 18312434
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Performance of preferentially expressed antigen in melanoma (PRAME) immunohistochemistry for metastatic melanoma in cytology specimens.
    Saad M; Cantley R; Hao W; Wang Z; Thomas D; Pantanowitz L; Jin X
    Diagn Cytopathol; 2024 Jul; 52(7):362-368. PubMed ID: 38558495
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Fine-needle aspiration biopsy of malignant melanoma: a cytologic and immunocytochemical analysis.
    Simmons TJ; Martin SE
    Diagn Cytopathol; 1991; 7(4):380-6. PubMed ID: 1935517
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Acral lentiginous melanoma in situ: a study of nine cases.
    Kwon IH; Lee JH; Cho KH
    Am J Dermatopathol; 2004 Aug; 26(4):285-9. PubMed ID: 15249858
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Immunohistochemistry in melanocytic lesions: Updates with a practical review for pathologists.
    Saleem A; Narala S; Raghavan SS
    Semin Diagn Pathol; 2022 Jul; 39(4):239-247. PubMed ID: 35016807
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. An immunohistochemical study on paraffin sections.
    Colombari R; Bonetti F; Zamboni G; Scarpa A; Marino F; Tomezzoli A; Capelli P; Menestrina F; Chilosi M; Fiore-Donati L
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):17-24. PubMed ID: 3131953
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Unusual variants of malignant melanoma.
    Magro CM; Crowson AN; Mihm MC
    Mod Pathol; 2006 Feb; 19 Suppl 2():S41-70. PubMed ID: 16446716
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Loss of Conventional Melanocytic Markers in Malignant Melanoma and Lymph Node Metastasis; an Uncommon but Dangerous Pitfall.
    Chang O; Argenyi Z
    Am J Dermatopathol; 2017 Oct; 39(10):760-763. PubMed ID: 27759690
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Lessons to be learned: a case study approach. Malignant melanoma of soft tissue.
    Dewan M; Malatani TS; Ansari MA
    J R Soc Promot Health; 2005 Jan; 125(1):42-6. PubMed ID: 15712852
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Metastatic signet-ring cell melanoma in a patient with an unknown primary tumor. Histologic, immunohistochemical, and ultrastructural findings.
    Eckert F; Baricević B; Landthaler M; Schmid U
    J Am Acad Dermatol; 1992 May; 26(5 Pt 2):870-5. PubMed ID: 1613153
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Malignant melanoma within an intradermal nevus.
    Tajima Y; Nakajima T; Sugano I; Nagao K; Kondo Y
    Am J Dermatopathol; 1994 Jun; 16(3):301-6. PubMed ID: 7943639
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis.
    Weyers W; Bonczkowitz M; Weyers I; Bittinger A; Schill WB
    Am J Dermatopathol; 1996 Dec; 18(6):560-6. PubMed ID: 8989926
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Expression of Sox-9 in metastatic melanoma--a potential diagnostic pitfall.
    Rao P; Fuller GN; Prieto VG
    Am J Dermatopathol; 2010 May; 32(3):262-266. PubMed ID: 20098296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 614.